Status:
RECRUITING
Registry Study on "Control Nocturnal Hypertension to Reach the Target "
Lead Sponsor:
Shanghai Institute of Hypertension
Conditions:
Nocturnal Hypertension
Eligibility:
All Genders
50-79 years
Brief Summary
Ambulatory blood pressure monitoring (ABPM) is a major innovation in the history of hypertension diagnosis. In clinical practice, the most well established indication for using ABPM is to identify pat...
Eligibility Criteria
Inclusion
- Age 50-79 years old
- Clinical diagnosed hypertension with the use of antihypertensive drugs
- Nocturnal hypertension ( nocturnal systolic blood pressure ≥ 130 mmHg and/or nocturnal diastolic blood pressure ≥ 80 mmHg)
- A 24-hour ambulatory blood pressure monitoring was performed with validated equipment.
- Willing to provide information about disease history and blood biochemical test data within 6 months.
- Sign the informed consent
Exclusion
- Without antihypertensive drug use
- Hospitalized hypertension patients
- Non-compliant patient
Key Trial Info
Start Date :
December 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
4500 Patients enrolled
Trial Details
Trial ID
NCT04137549
Start Date
December 1 2019
End Date
December 31 2026
Last Update
January 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ruijin Hospital
Shanghai, Shanghai Municipality, China, 200025